Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach

Detalles Bibliográficos
Autores principales: Grant, A, Kamuntu, Y, Read, P, Kulasegaram, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113035/
http://dx.doi.org/10.1186/1758-2652-13-S4-P33
_version_ 1782205873296244736
author Grant, A
Kamuntu, Y
Read, P
Kulasegaram, R
author_facet Grant, A
Kamuntu, Y
Read, P
Kulasegaram, R
author_sort Grant, A
collection PubMed
description
format Online
Article
Text
id pubmed-3113035
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130352011-06-13 Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach Grant, A Kamuntu, Y Read, P Kulasegaram, R J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113035/ http://dx.doi.org/10.1186/1758-2652-13-S4-P33 Text en Copyright ©2010 Grant et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Grant, A
Kamuntu, Y
Read, P
Kulasegaram, R
Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach
title Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach
title_full Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach
title_fullStr Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach
title_full_unstemmed Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach
title_short Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach
title_sort switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113035/
http://dx.doi.org/10.1186/1758-2652-13-S4-P33
work_keys_str_mv AT granta switchingtoanukesparingraltegraviratazanavircombinationanindividualisedapproach
AT kamuntuy switchingtoanukesparingraltegraviratazanavircombinationanindividualisedapproach
AT readp switchingtoanukesparingraltegraviratazanavircombinationanindividualisedapproach
AT kulasegaramr switchingtoanukesparingraltegraviratazanavircombinationanindividualisedapproach

Ejemplares similares